(Q41038067)

25 September 2017

1 reference

title

Clinical use of cyclosporin in rheumatoid arthritis (English)

1 reference

25 September 2017

2

P Emery

0 references

author name string

C Richardson

series ordinal

1

1 reference

25 September 2017

1 January 1995

1 reference

25 September 2017

1 reference

25 September 2017

50 Suppl 1

1 reference

25 September 2017

26-36

1 reference

Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.

25 September 2017

1 reference

12 December 2020

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group

1 reference

12 December 2020

Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients

1 reference

12 December 2020

Cyclosporin A inhibits CD40 ligand expression in T lymphocytes

1 reference

12 December 2020

Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1

1 reference

12 December 2020

An international consensus report: the use of cyclosporin A in rheumatoid arthritis

1 reference

12 December 2020

Lymphocytapheresis--a feasible treatment for rheumatoid arthritis

1 reference

12 December 2020

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

12 December 2020

Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity

1 reference

12 December 2020

Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.

1 reference

12 December 2020

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

12 December 2020

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

1 reference

12 December 2020

Cyclosporin A in rheumatoid arthritis: overview of efficacy

1 reference

12 December 2020

Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis

1 reference

12 December 2020

Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation

1 reference

12 December 2020

The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

1 reference

12 December 2020

Synovial T lymphocyte–specific immune response toChlamydia trachomatis in Reiter's disease

1 reference

12 December 2020

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

1 reference

12 December 2020

Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study

1 reference

12 December 2020

Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group

1 reference

12 December 2020

Role of endothelin in cyclosporine-induced glomerular dysfunction.

1 reference

12 December 2020

Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis

1 reference

12 December 2020

Malignancies in rheumatoid arthritis patients treated with cyclosporin A

1 reference

12 December 2020

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

1 reference

12 December 2020

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

1 reference

12 December 2020

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

1 reference

12 December 2020

Modes of action of FK506, cyclosporin A, and rapamycin.

1 reference

12 December 2020

Effects of the new anti-lymphocytic peptide cyclosporin A in animals

1 reference

12 December 2020

T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis

1 reference

12 December 2020

Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation

1 reference

12 December 2020

A cost-effectiveness analysis of cyclosporine in cadaveric kidney transplantation

1 reference

12 December 2020

Coordinate expression of src family protooncogenes in T cell activation and its modulation by cyclosporine

1 reference

12 December 2020

A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis

1 reference

12 December 2020

Cyclosporin clinical pharmacokinetics

1 reference

12 December 2020

Methotrexate in rheumatoid arthritis. An update

1 reference

12 December 2020

The role of CD40 in the regulation of humoral and cell-mediated immunity

1 reference

12 December 2020

Dissection of the mechanisms of immune injury in rheumatoid arthritis, using total lymphoid irradiation

1 reference

12 December 2020

Absorption of cyclosporine A after oral dosing

1 reference

12 December 2020

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

1 reference

12 December 2020

Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies).

1 reference

12 December 2020

Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome

1 reference

12 December 2020

Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients

1 reference

12 December 2020

HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region

1 reference

12 December 2020

The mechanism of action of FK-506 and cyclosporin A.

1 reference

12 December 2020

The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review

1 reference

12 December 2020

10.2165/00003495-199500501-00005

Identifiers

DOI

0 references

PubMed ID

8714796

1 reference

PubMed ID

8714796